Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
BCG intravesical solution
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
URO-BCG-4 : Bladder Tumors Immunotherapy
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2003/081/HP
, NCT00213655
2.
Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG for Superficial Bladder Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
102.1
, NCT00384891
3.
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
09-118
, NCT00974818
4.
Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CR-60/9150
, NCT00694915
5.
Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-Muscle Invasive Lower Urinary Tract Urothelial Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
Sutent V2 / November 4, 2008
, NCT00794950
6.
Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CO08807
, NCT00880854
7.
Markers of Response to Intravesical Bladder Cancer Therapy
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
LAB05-0326
, NCT01007058
Select All on Page
Help with Results
